Guinea-Bissau vs Indonesia: Immunization, Hib3
Guinea-Bissau
68.0%
in 2024
Indonesia
69.0%
in 2024
Guinea-Bissau rank
171st
Indonesia rank
169th
Immunization, Hib3 over time
- Guinea-Bissau
- Indonesia
How they compare
Indonesia currently reports 69.0% against 68.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 5 times across 12 shared years of data; in 2013 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 171st and Indonesia ranks 169th of 191 countries.
Across the 2 decades both report, Guinea-Bissau averaged higher in 1 and Indonesia in 1.
Head to head by decade
| Decade | Guinea-Bissau | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.3% | 64.0% | 19.3% | Guinea-Bissau |
| 2020s | 71.4% | 72.0% | 0.6% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Guinea-Bissau or Indonesia?
- Indonesia, at 69.0% against 68.0% in Guinea-Bissau as of 2024.
- What is the difference in immunization, hib3 between Guinea-Bissau and Indonesia?
- 1.0%, with Indonesia ahead.
- How many years of comparable data are there for Guinea-Bissau and Indonesia?
- 12 years are reported by both, from 2013 to 2024.
- How do Guinea-Bissau and Indonesia rank globally for immunization, hib3?
- Guinea-Bissau ranks 171st and Indonesia ranks 169th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.